COMPASS THERAPEUTICS, INC. (CMPX)
Clinical trial NCT05624268 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. start date: 2023-01-19 → 2023-01-24 3. completion date: 2026-04-01 → 2026-04-15 4. enrollment: 255 → 258 participants 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical